As of Aug 28
| +0.14 / +6.45%|
The 3 analysts offering 12-month price forecasts for IntelliPharmaCeutics International Inc have a median target of 8.00, with a high estimate of 12.00 and a low estimate of 8.00. The median estimate represents a +246.32% increase from the last price of 2.31.
The current consensus among 3 polled investment analysts is to Buy stock in IntelliPharmaCeutics International Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.